Heald et al. (2006) reported in 163 type 2 diabetes patients that 125 of those patients with metabolic syndrome patients presented lower levels of IGFBP2 than those in 38 non-metabolic syndrome participants [4]. This evidence concerns the gene IGFBP2 and type 2 diabetes mellitus.